LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 14, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC) common stock pursuant and/or traceable to the Company's October 2024 initial public offering (the “IPO”).

LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) securities between March 7, 2024 and May 23, 2025, inclusive (the “Class Period”).

LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 17, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) common stock between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”).

Viatris continues to struggle with declining sales across all regions, with Q2-2025 net sales down 7% year over year. VTRS's Indore plant issues have significantly impacted results, but a full recovery in 2026 could lead to earnings beats versus consensus estimates. Despite capital returns, persistent sales declines and lack of progress in debt reduction raise concerns about VTRS's long-term investment viability.

India's government has drafted a proposal to ease foreign investment rules to allow e-commerce companies like Amazon to buy products directly from Indian sellers and then sell them to overseas customers, a document showed.

KMT faces revenue pressure as weakness in the Metal Cutting and Infrastructure segments weighs on its growth outlook.

LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”).

Uber is adding discounts on fresh groceries to its app. The discounts, called "Fresh Days," will apply to some produce, meat, dairy, and other fresh items.

HWM and TXT are both benefiting from aerospace tailwinds, but only one looks set to deliver stronger upside in 2025.

Hangzhou, China, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into an agreement with several investors for the purchase and sale of 38,999,334 of the Company's Class A ordinary share, par value $0.0005 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.075 per share in a registered direct offering (the “Offering”). The purchase price for …

LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 18, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Quanex Building Products Corporation (“Quanex” or the “Company”) (NYSE: NX) securities between December 12, 2024 and September 5, 2025, inclusive (the “Class Period”).

Amazon agreed Thursday to pay $2.5 billion to settle allegations from a U.S. regulator that it used deceptive practices to enroll consumers in Amazon Prime and made it difficult to cancel subscriptions.

NEW ORLEANS, Sept. 25, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated (NasdaqGS: CYTK), if they purchased or otherwise acquired the Company's securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

The case could rewrite the rules on how businesses make money on Google's smartphone operating system.

Accenture plc (NYSE:ACN ) Q4 2025 Earnings Call September 25, 2025 8:00 AM EDT Company Participants Alexia Quadrani Julie T. Sweet - CEO & Chairman Angie Park - Chief Financial Officer Conference Call Participants Tien-Tsin Huang - JPMorgan Chase & Co, Research Division David Koning - Robert W.

The near-term outlook for the Zacks Paper and Related Products industry is uncertain. Stocks like SW and SUZ are braving the industry headwinds.

KBR, Inc. KBR has announced a tax-free spin-off of its Mission Technology Solutions (MTS) segment, which is expected to be complete by mid-to-late 2026. Upon the final approval of its board of directors and satisfying all the customary conditions, there will be the formation of two pure-play companies, New KBR, comprising the Sustainable Technology Solutions (STS) segment, and SpinCo, comprising the MTS segment.

JD.com (JD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Forge Global remains a "Buy," with expectations of turning EBITDA-positive in 2026 and benefiting from a recent partnership with Silicon Valley Bank. The exclusive collaboration with SVB expands FRGE's client reach, and enhances cross-selling opportunities. FRGE's cost management, European expansion, and the accretive acquisition of Accuidity Capital strengthen its path toward profitability and higher valuation multiples.

CME Group Inc (NASDAQ:CME) shares received an upgrade to ‘Buy' from ‘Hold' from the analysts at Citi on Thursday, saying the stock represents a positive risk/reward at current levels given catalysts ahead, the capital return story and defensive nature of the platform. They have a target price of US$300 on stock, implying an estimated total return of 18%.